|
|
|
Volumn 1, Issue 293-301, 1998, Pages 289-301
|
|
Rifaximin in inactive Crohn's Disease: Effect on the intestinal protein loss as assessed by the fecal α1-antitrypsin clearance
a
a
|
|
Author keywords
1 antitripsin; Crohn's disease; Rifaximin
|
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
RIFAXIMIN;
TUBERCULOSTATIC AGENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DOUBLE BLIND PROCEDURE;
FECES;
FEMALE;
FOLLOW UP;
HUMAN;
ILEUM;
LONGITUDINAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PROSPECTIVE STUDY;
PROTEIN DEPLETION;
|
|
EID: 0031786014
PISSN: 13695207
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (35)
|
